Skip to content

Association between diabetic neuropathy and abnormality of bone marrow-derived cells in diabetic patients

Association between diabetic neuropathy and abnormality of bone marrow-derived cells in diabetic patients - Association between diabetic neuropathy and abnormality of bone marrow-derived cells

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000044169
Enrollment
40
Registered
2021-05-15
Start date
2019-10-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Interventions

None listed

Sponsors

Shiga University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with type 2 diabetic mellitus

Exclusion criteria

Exclusion criteria: 1) Pregnant and lactating women 2) Patients undergoing treatment for autoimmune diseases or with a history of such diseases 3) Patients undergoing treatment for malignant tumors 4) Patients being treated with steroids or immunosuppressive drugs 5) Patients with type 1 diabetes mellitus

Design outcomes

Primary

MeasureTime frame
Amount of peripheral blood bone marrow derived cells and expressed proteins

Countries

Japan

Contacts

Public ContactItsuko Miyazawa

Shiga University of Medical Science Internal medicine

shimojo@belle.shiga-med.ac.jp0775482222

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026